Nano Ozonized Oil Trigger ROS Production and ɣH2AX Cell Positivity of B-16 Melanoma and OV-90 Ovarian Cells
- 1 June 2022
- journal article
- Published by Bulent Evcevit University in Karaelmas Science and Engineering Journal
- Vol. 12 (1) , 38-46
Abstract
Tumor hypoxia is a restrictive factor for cancer treatment. Ozone therapy, used to decrease or prevent the hypoxia in tumor. In this study, it is aimed to use ozonized oil nanoemulsions (OZNEs) to overcome the limitations of ozone therapy in cancer research. The influence of OZNE against cancer cell lines is evaluated by Reactive Oxygen Species (ROS) and ɣH2AX assays. For both B-16 melanoma and OV-90 cell lines, ROS production levels increased due to the increase in OZNE doses (0.85% to 14.88% and 1.94% to 58.58% for B-16 and OV-90 cell lines, respectively). 5-fold higher ɣH2AX cell positivity’s determined in OV-90 cells compared to B-16 melanoma cells. OZNE treatment could provide a new effective method to damage cancer cells in the future.Keywords
Funding Information
- Bülent Ecevit University Scientific Research Projects (2016-39971044-02)
This publication has 27 references indexed in Scilit:
- Biodegradable Nanoprodrugs: “Delivering” ROS to Cancer Cells for Molecular Dynamic TherapyAdvanced Materials, 2019
- Synthesis and Characterization of Ozonated Oil NanoemulsionsJournal of the American Oil Chemists' Society, 2018
- ROS-dependent signal transductionCurrent Opinion in Cell Biology, 2015
- The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damageCellular Signalling, 2012
- Differential usage of non-homologous end-joining and homologous recombination in double strand break repairDNA Repair, 2006
- Influences of ozone exposure upon macrophage responsivity to N-formyl-methionyl-leucyl-phenylalanine: mobility and metabolic changesToxicology in Vitro, 2004
- Histone H2AXCell, 2003
- Role of reactive oxygen species (ROS) in apoptosis inductionApoptosis, 2000
- Reactive Oxygen-Mediated Protein Oxidation in Aging and DiseaseChemical Research in Toxicology, 1997
- OZONE IN CHRONIC MIDDLE-EAR DEAFNESS.The Lancet, 1902